GSK, iTeos lung cancer drug outperforms Jemperli (NASDAQ:ITOS)
koto_feja/E+ through Getty Pictures iTeos Therapeutics (NASDAQ:ITOS) introduced Saturday that its experimental most cancers doublet remedy developed with GSK (NYSE:GSK) ...
Tag: lung
AstraZeneca reports disappointing Phase 3 data for lung cancer ADC (NASDAQ:AZN)
IvelinRadkov AstraZeneca (NASDAQ:AZN) and Daiichi Sankyo (OTCPK:DSKYF) (OTCPK:DSNKY) stated {that a} Part 3 research of their antibody drug conjugate, or ...
In other news, this week: Revolut Business revenue exceeded €450M, Root Signal bags €2.5M for GenAI adoption, HEPTA Medical raises €5.7M for lung cancer therapy and more – Silicon Canals
In at the moment’s fast-paced world, with new improvements rising each minute, it's straightforward to really feel overwhelmed in the ...
US FDA approves J&J’s chemotherapy-free treatment for lung cancer By Reuters
By Bhanvi Satija and Christy Santhosh (Reuters) -The U.S. well being regulator on Tuesday permitted Johnson & Johnson (NYSE:)'s chemotherapy-free ...
Merck coformulation fails to meet key goal in lung cancer trial (NYSE:MRK)
Merck (NYSE:MRK) stated on Thursday that its investigational coformulation for metastatic non-small cell lung most cancers (NSCLC) didn't present an ...
